Phase I Study of Tivantinib Plus Bevacizumab

Trial Profile

Phase I Study of Tivantinib Plus Bevacizumab

Phase of Trial: Phase I

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Tivantinib (Primary) ; Bevacizumab
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 03 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by
    • 11 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top